Fengyan Yu

5.1k total citations · 2 hit papers
44 papers, 4.1k citations indexed

About

Fengyan Yu is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Fengyan Yu has authored 44 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cancer Research, 23 papers in Molecular Biology and 20 papers in Oncology. Recurrent topics in Fengyan Yu's work include MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (14 papers) and Circular RNAs in diseases (8 papers). Fengyan Yu is often cited by papers focused on MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (14 papers) and Circular RNAs in diseases (8 papers). Fengyan Yu collaborates with scholars based in China, United States and Singapore. Fengyan Yu's co-authors include Erwei Song, Herui Yao, Chang Gong, Judy Lieberman, Fengxi Su, Xiaoqu Hu, Pengcheng Zhu, Yijun Huang, Xiaoqin Zhang and Qiuhui Pan and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Fengyan Yu

39 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells

2007 1.5k citations Fengyan Yu, Herui Yao et al. profile →
CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3

2011 507 citations Yandan Yao, Chang Gong et al. Cancer Cell profile →

Peers

Countries citing papers authored by Fengyan Yu

Since Specialization

Citations

This map shows the geographic impact of Fengyan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengyan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengyan Yu more than expected).

Fields of papers citing papers by Fengyan Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengyan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengyan Yu. The network helps show where Fengyan Yu may publish in the future.

Co-authorship network of co-authors of Fengyan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Fengyan Yu. A scholar is included among the top collaborators of Fengyan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengyan Yu. Fengyan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Machine learning for the prediction of diabetes-related amputation: a systematic review and meta-analysis of diagnostic test accuracy 2025 ·Clinical and Experimental Medicine ·Zhigang Chen, Xinliang Liu, Simeng Li, (unknown), Hsiang Tan, Fengyan Yu, (unknown), (unknown)	0
2	Expression of Concern: Reduced miR-128 in Breast Tumor–Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5 2024 ·Clinical Cancer Research ·(unknown), Fengyan Yu, (unknown), Juan Feng, Wei Tang, Herui Yao, (unknown), Jianing Chen, Fengxi Su, Yan Zhang, Erwei Song	1
3	Geographical Traceability of <i>Clinacanthus nutans</i> with Near-Infrared Pectroscopy and Chemometrics 2022 ·American Journal of Analytical Chemistry ·Fengyan Yu, Jinfang Ma, 一朗漆崎, Han Wook Song, Guiliang Tan, Furong Huang, (unknown)	2
4	Shaoyao Decoction Inhibits Inflammation and Improves Intestinal Barrier Function in Mice With Dextran Sulfate Sodium-Induced Colitis 2021 ·Frontiers in Pharmacology ·Honggang Chi, (unknown), Mengting Chen, Jiantao Lin, Shu‐Hua Zhang, Fengyan Yu, Jun Zhou, Xuebao Zheng, Ying Zou	23
5	Establishment and Validation of a Preoperative MRI-based Nomogram for Predicting the Risk of Malignancy in Patients with Breast Tumor 2020 ·Journal of Cancer ·Jianguo Lai, (unknown), Hongli Wang, Yi Sun, Yudong Li, Huan Tian, (unknown), Cui Tan, Huanhuan Liu, Fengyan Yu	2
6	Personalized prognostic model incorporating axillary lymph node ratio and molecular subtype for predicting long-term survival in node-positive patients with breast cancer: A large-scale, multicenter study 2018 ·Annals of Oncology ·Jianguo Lai, (unknown), Heran Deng, Jingwen Peng, (unknown), (unknown), Fengyan Yu, Mu‐Sheng Zeng, (unknown), Fengxi Su	1
7	A nomogram for predicting the likelihood of axillary lymph node metastasis in breast cancer patients based on ultrasonographic-pathologic features 2017 ·Annals of Oncology ·Jianguo Lai, (unknown), (unknown), (unknown), Songying Shen, Yaping Yang, Ran Gu, Feilong Liu, Yue Hu, (unknown), Fengyan Yu	0
8	Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis 2016 ·World Journal of Gastroenterology ·Fengyan Yu, Shaogang Huang, Haiyan Zhang, Hua Ye, Honggang Chi, Ying Zou, (unknown), (unknown)	32
9	Reduced Let-7a Is Associated with Chemoresistance in Primary Breast Cancer 2015 ·PLoS ONE ·Jiannan Wu, Shunrong Li, Weijuan Jia, Heran Deng, Kai Chen, Liling Zhu, Fengyan Yu, Fengxi Su	34
10	Effects of baicalin in CD4 + CD29 + T cell subsets of ulcerative colitis patients 2014 ·World Journal of Gastroenterology ·Fengyan Yu	41
11	Pyk2 and Src Mediate Signaling to CCL18‐Induced Breast Cancer Metastasis 2013 ·Journal of Cellular Biochemistry ·Haiyan Li, (unknown), Wei Wu, Fengyan Yu, Herui Yao, Qiang Liu, Erwei Song, (unknown)	45
12	The Overexpression of Hypomethylated miR-663 Induces Chemotherapy Resistance in Human Breast Cancer Cells by Targeting Heparin Sulfate Proteoglycan 2 (HSPG2) 2013 ·Journal of Biological Chemistry ·Haiyan Hu, Shuqin Li, Xiuying Cui, Xiaobin Lv, Yu Jiao, Fengyan Yu, Herui Yao, Erwei Song, Yongsong Chen, Minghui Wang, Ling Lin	101
13	MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival 2012 ·PLoS ONE ·Wei Tang, Jiujun Zhu, Shicheng Su, Wei Wu, Qiang Liu, Fengxi Su, Fengyan Yu	114
14	Reduced miR-128 in Breast Tumor–Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5 2011 ·Clinical Cancer Research ·Yinghua Zhu, Fengyan Yu, Yu Jiao, Juan Feng, Wei Tang, Herui Yao, Chang Gong, Jianing Chen, Fengxi Su, Yan Zhang, Erwei Song	211
15	CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3 2011 ·Cancer Cell ·Jingqi Chen, Yandan Yao, (unknown), Fengyan Yu, Shicheng Su, Jianing Chen, Bodu Liu, Hui Deng, Fengsong Wang, Ling Lin, Herui Yao, Fengxi Su, Karen S. Anderson, Qiang Liu, Mark E. Ewen, Xuebiao Yao, Erwei Song	18
16	Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro 2011 ·British Journal of Cancer ·Gang Wu, Fengyan Yu, Zhiyu Xiao, Kang Xu, Jia Xu, Wei Tang, Jing Wang, Erwei Song	77
17	miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro 2011 ·Chinese Journal of Cancer ·Xiaobin Lv, Yu Jiao, (unknown), Haiyan Hu, Xiuying Cui, Tianxin Lin, Erwei Song, Fengyan Yu	64
18	Plasma miR-221 as a Predictive Biomarker for Chemoresistance in Breast Cancer Patients who Previously Received Neoadjuvant Chemotherapy 2011 ·Onkologie ·Ruihua Zhao, Jiannan Wu, Weijuan Jia, Chang Gong, Fengyan Yu, (unknown), Kai Chen, Jianrong He, (unknown)	61
19	miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases 2009 ·PLoS ONE ·Derek M. Dykxhoorn, (unknown), Huangming Xie, Fengyan Yu, Ashish Lal, Fabio Petrocca, Denis Martinvalet, Erwei Song, Bing Lim, Judy Lieberman	260
20	Stable RNA interference of ErbB-2 gene synergistic with epirubicin suppresses breast cancer growth in vitro and in vivo 2006 ·Biochemical and Biophysical Research Communications ·Xiaoqu Hu, Fengxi Su, Li Qin, Weijuan Jia, Chang Gong, Fengyan Yu, (unknown), Erwei Song	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact